Misty Young, PA
Physician Assistant · Temple, TXNPI 1295870624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $297 and has fallen 79.0% since, to $62 in 2024.
Across 33 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vifor Pharma, Inc.$125
- AstraZeneca$81
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$63
- Pfizer$52
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$51
- Johnson & Johnson$40
- plus $290 from 13 others
What the payments were for
- Food & beverage$701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vifor Pharma, Inc. | 6 | $125 |
| AstraZeneca(2 entities) | 3 | $81 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $63 |
| Pfizer | 2 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $51 |
| Johnson & Johnson | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Bayer | 1 | $26 |
| Biogen | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Shionogi Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Novartis | 1 | $16 |
| Chiesi USA, Inc. | 1 | $12 |
How this compares
$701 in reported general payments places this provider in the 55th percentile of 8,308 physician assistant providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 22 | $312 |
| Metoprolol Succinate | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Temple
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.